Healthcare Business International interviewed Nelson Advisors partner Lloyd Price discussing Healthbridge's acquisition of AI scribe Nora. “The acquisition highlights a broader shift in the industry, as companies are leaning more toward acquisitions instead of building everything in-house,” Lloyd Price, partner at M&A advisory firm Nelson Advisors told HBI.

Nelson Advisors Partner Lloyd Price has been interviewed by Healthcare Business International regarding hims & hers acquisition of Australian Digital Health platform Eucalyptus Lloyd Price, partner at M&A advisory firm Nelson Advisors, a consultancy that focuses exclusively on the healthcare technology (healthtech) and medical technology (medtech) sectors, tells HBI the acquisition serves both defensive and offensive purposes. “Strategically, it hedges against rising US regul

The outpatient sector in Europe, long fragmented into millions of providers, is the new frontier for consolidation. And no market is...